We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 10.46%
3 Healthcare 9.6%
4 Financials 9.53%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XPEL icon
2001
XPEL
XPEL
$1.39B
$38K ﹤0.01%
1,474
– –
FBMS
2002
DELISTED
The First Bancshares, Inc.
FBMS
$38K ﹤0.01%
1,827
– –
ATRS
2003
DELISTED
Antares Pharma, Inc.
ATRS
$38K ﹤0.01%
14,209
– –
APEI icon
2004
American Public Education
APEI
$828M
$37K ﹤0.01%
1,323
– –
CHEF icon
2005
Chefs' Warehouse
CHEF
$4.57B
$37K ﹤0.01%
2,573
+542
+27% +$7.72K
CRNX icon
2006
Crinetics Pharmaceuticals
CRNX
$8.96B
$37K ﹤0.01%
2,390
– –
CTBI icon
2007
Community Trust Bancorp
CTBI
$1.44B
$37K ﹤0.01%
1,316
– –
CUE icon
2008
Cue Biopharma
CUE
$131M
$37K ﹤0.01%
82
– –
CVM icon
2009
CEL-SCI Corp
CVM
$26M
$37K ﹤0.01%
96
– –
OTRK
2010
DELISTED
Ontrak
OTRK
$37K ﹤0.01%
7
– –
RMR icon
2011
The RMR Group
RMR
$346M
$37K ﹤0.01%
1,361
– –
UVSP icon
2012
Univest Financial
UVSP
$1.19B
$37K ﹤0.01%
2,577
– –
WT icon
2013
WisdomTree
WT
$3.44B
$37K ﹤0.01%
11,656
– –
PRSU
2014
Pursuit Attractions and Hospitality Inc
PRSU
$1.29B
$37K ﹤0.01%
1,775
– –
EGRX
2015
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$37K ﹤0.01%
867
– –
RPT
2016
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$37K ﹤0.01%
6,804
– –
CLVS
2017
DELISTED
Clovis Oncology, Inc.
CLVS
$37K ﹤0.01%
6,387
– –
FFG
2018
DELISTED
FBL Financial Group
FFG
$37K ﹤0.01%
766
– –
DGII icon
2019
Digi International
DGII
$3.23B
$36K ﹤0.01%
2,313
– –
KREF
2020
KKR Real Estate Finance Trust
KREF
$502M
$36K ﹤0.01%
2,170
– –
OBK icon
2021
Origin Bancorp
OBK
$1.69B
$36K ﹤0.01%
1,666
– –
PSR icon
2022
Invesco Active US Real Estate Fund
PSR
$59.9M
$36K ﹤0.01%
445
– –
RIGL icon
2023
Rigel Pharmaceuticals
RIGL
$762M
$36K ﹤0.01%
1,481
+220
+17% +$5.4K
SRRK icon
2024
Scholar Rock
SRRK
$6.46B
$36K ﹤0.01%
2,007
– –
STOK icon
2025
Stoke Therapeutics
STOK
$2.02B
$36K ﹤0.01%
1,079
– –
79 80
81
82 83

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.